DMAC – diamedica therapeutics inc. (US:NASDAQ)
Stock Stats
News
We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate [Yahoo! Finance]
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
DiaMedica Therapeutics GAAP EPS of -$0.15 in-line [Seeking Alpha]
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results
Form 10-Q DiaMedica Therapeutics For: Sep 30
Form 8-K DiaMedica Therapeutics For: Nov 13
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.